Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan

Journal of the Formosan Medical Association

Volumn 102, Issue 7, 2003, Pages 459-464

  Lee, Wei Jei ^a   Chen, Hsin Hung ^b   Wang, Weu ^a   Wei, Po Li ^a   Lin, Ching Mei ^a   Huang, Ming Te ^a,c  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Diabetes mellitus; Hyperlipidemia; Hypertension; Metabolic syndrome X; Morbid obesity

Indexed keywords

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; LIFE EXPECTANCY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PATIENT REFERRAL; PATIENT SELECTION; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TAIWAN; WEIGHT REDUCTION;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 0347531395     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Must A, Spadano J, Coakley EH, et al: The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
2. Allison DB, Fontaine KR, Manson JE, et al: Annual death attributable to obesity in the United Statese. JAMA 1999;284:1530-8.
3. Calle EE, Thun MJ, Petrelli JM, et al: Body-mass index and mortality in a prospective cohort of U.S. adults. NEJM 1999; 341:1097-105.
4. Tikkanen MS, Tuomilehto J: Multiple metabolic syndrome (syndrome X). Ann Med 1992;24:461-89.
5. Schmidt MI, Watson RL, Duncan BB, et al: Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996;699-706.
6. Reaven GM: Banting Lecture 1998: Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
7. Yarnell JWG, Patterson CC, Bainton D, et al: Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart 1998; 78:248-52.
8. Must A, Spadano J, Coakley EH, et al: The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
9. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. JAMA 2002;287:356-9.
10. O'Brien PE, Brown WA, Smith PJ, et al: Prospective study of a laparscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg 1999;86:113-8.
11. Adami GF, Ravera G, Marinari GM, et al: Metabolic syndrome in severely obese patients. Obest Surg 2001;11:543-5.
12. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel of Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md: National Institutes of Heatlh;2001. NIH publication 01-3670.
13. Chen KM, Lee WJ, Lai HS, et al: Fifteen years' experience with gastric partitioning for obesity treatment. J Formos Med Assoc 1998;97:381-6.
14. McMahon SW, Blacket RB, McDonald GJ: Obesity, alcohol consumption and blood pressure in Australian men and women. National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens 1984;2:85-91.
15. WHO: Obesity: Preventing and managing the global epidemic. Geneva: WHO; 1998:1-276.
16. WHO: The Asia-Pacific perspective Redefining obesity and its treatment. Geneva: WHO; 2000:1-120.
17. Bjorntorp P: Visceral obesity: a "civilizaiton syndrome". Obes Res 1993;1:206-22.
18. Mcternan CL, Ternan PG, Herte AL, et al: Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-7.
19. Chang CJ, Wu CH, Yao WJ, et al: Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women. Int J Obes 2000;24:1699-704.
20. Ferranini E, Haffner SM, Mitchell BD, et al: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22.
21. Meigs J, D'Agostino RB, Wilson PWF, et al: Risk variable clustering in the insulin resistance syndrome: The Framingham offspring study. Diabetes 1997;46:1594-600.
22. Lee YJ, Tsai JCR: ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002;25:1002-8.
23. Lee WJ, Lai IR, Huang MT, et al: Laparoscopic versus open vertical banded gastroplasty for the treatment of morbid obesity. Surg Laparosc, Endosc Percutan Tech 2001;11:9-13.
24. Carson JL, Ruddy ME, Duff AE, et al: The effect of gastric bypass surgery on hypertension in morbidly obese patients. Ann Intern Med 1994;154:193-200.
25. Pories WJ, Swanson MS, MacDonald KG, et al: Who would have though it? An operation proved to be the most effective therapy of adult-onset on diabetes mellitus. Ann Surg 1995; 222:339-52.
26. Sjostorm CD, Lissner L, Wedel H, et al: Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS interventional study. Obes Res 1999;7:477-84.